References
- 1. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109:320.
- 2. O’Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004; 15:1046.
- 3. Wattanakit K, Folsom AR, Selvin E, et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007; 18:629.10.1681/ASN.2005111204
- 4. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–495.
- 5. Eggers PW, Godhes D, Pugh J. Nontraumatic extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999;56 (4):1524-3310.1046/j.1523-1755.1999.00668.x
- 6. Menon V. Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005;68(4):1413-8.
- 7. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Köttgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Apr 20. pii: S0140-6736(17)30788-2. doi: 10.1016/S0140-6736(17)30788-2.10.1016/S0140-6736(17)30788-2
- 8. Authors/Task Force Members:, Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281-344.
- 9. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007 Jul 3;116(1):85-97.
- 10. Gross P, Six I, Kamel S, Massy ZA. Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification. Circ J. 2014;78(10):2339-46.
- 11. Bosevski M, Borozanov V, Tosev S, Georgievska-Ismail Lj. Is assessment of eripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease? Int J Cardiol. 2009 Jan 9;131(2):290-2.
- 12. Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study. Am J Kidney Dis. 2012 Nov;60(5):804-1110.1053/j.ajkd.2012.06.017
- 13. Chang A, Kramer H. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney diseaseand cardiovascular disease risk prediction. Nephron Clin Pract. 2011;119(2):c171-7;
- 14. Dzekova Vidimliski P, Ivanovski N, Bosevski M, Busletic I, Sikole A. Association betwwn Hepatitis C and Carotid IMT in renal transplant recipient. Int journal of artificial organs 32(7):443-443
- 15. Selim G, Stojceva-Taneva O, Zafirovska K, Sikole A, Gelev S, Dzekova P, Stefanovski K, Koloska V, Polenakovic M. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients. Prilozi. 2006 Jul;27(1):133-44.
- 16. Silveberg D. Cardio-renal anemia iron deficiency syndrome (CRAID). Proceeding of 3rd Cardionephrology Congress 2017;116-120
- 17. Patel SI, Chakkera HA, Wennberg PW, Liedl DA, Alrabadi F, Cha SS, Hooley DD, Amer H, Wadei HM, Shamoun FE. Peripheral arterial disease preoperatively may predict graft failure and mortality in kidneytransplant recipients. Vasc Med. 2017;22(3):225-230.10.1177/1358863X16689830
- 18. Rajagopalan S, Dellegrottaglie S, Furniss AL,. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006; 114: 1914–1922
- 19. Gelev S, Spasovski G, BosevskiM, Tosev S, Sikole A. Different Ankle Brachial Index Levels in Asymptomatic Hemodialysis Patients. Bantao J 2006;4(2):41-6
- 20. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(4)(suppl 3):S1-S153.
- 21. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-S75.
- 22. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-e654.
- 23. Bosevski M, Soedamah-Muthu SS. Blood urea level and diabetes duration are independently associated with ankle-brachial index in type 2 diabetic patients. Diabetes Metab Syndr. 2012;6(1):32-5.